Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELDORADO: Prevention of Radiation Induced Liver Toxicity
NCT01149304Phase 2Completed
- Sponsor
- University of Magdeburg
- Start
- Jun 2009
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline, ursodeoxycholic acid, enoxaparin in radiation-induced liver disease (RILD), sponsored by University of Magdeburg. Started Jun 2009; status: completed.
02
Drugs
pentoxifyllineursodeoxycholic acidenoxaparin
03
Conditions
radiation-induced liver disease (RILD)
Beyond the preview
Go deeper on NCT01149304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149304.